tiprankstipranks
Pasithea Therapeutics Corp (KTTA)
NASDAQ:KTTA
US Market
KTTA
Pasithea Therapeutics Corp
RESEARCH TOOLSreports
Want to see KTTA full AI Analyst Report?

Pasithea Therapeutics Corp (KTTA) Stock News & Sentiment

149 Followers
Pasithea Therapeutics: Buy Rating Reiterated on PAS-004 Upside Potential and Strong Cash Runway; $3 Price Target Maintained
Premium
Ratings
Pasithea Therapeutics: Buy Rating Reiterated on PAS-004 Upside Potential and Strong Cash Runway; $3 Price Target Maintained
2d ago
KTTA
Pasithea Therapeutics Appoints New CMO, Updates Equity Incentives
Premium
Company Announcements
Pasithea Therapeutics Appoints New CMO, Updates Equity Incentives
18d ago
8K
KTTA
Pasithea Therapeutics Receives Nasdaq Minimum Bid Price Notice
Premium
Company Announcements
Pasithea Therapeutics Receives Nasdaq Minimum Bid Price Notice
3M ago
8K
KTTA
Pasithea Therapeutics Shareholders Approve Expanded Equity Authorization
Premium
Company Announcements
Pasithea Therapeutics Shareholders Approve Expanded Equity Authorization
4M ago
8K
KTTA
Pasithea Therapeutics: Buy Rating on Differentiated PAS-004, 2026 Clinical Catalysts, and Strengthened Cash Runway
Premium
Ratings
Pasithea Therapeutics: Buy Rating on Differentiated PAS-004, 2026 Clinical Catalysts, and Strengthened Cash Runway
4M ago
KTTA
Pasithea Therapeutics Regains Nasdaq Compliance
Premium
Company Announcements
Pasithea Therapeutics Regains Nasdaq Compliance
5M ago
8K
KTTA
3 Penny Stocks to Watch Now, 12/2/25
Premium
Market News
3 Penny Stocks to Watch Now, 12/2/25
6M ago
ADTX
BEAM
More KTTA News >

KTTA News on the Web

Analysts Offer Insights on Healthcare Companies: Jasper Therapeutics (JSPR), Pasithea Therapeutics Corp (KTTA) and RenovoRx (RNXT)
TipRanks News
Bullish
Pasithea Therapeutics Receives Nasdaq Minimum Bid Price Notice
TipRanks News
Bearish
Pasithea Therapeutics Shareholders Approve Expanded Equity Authorization
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Marker Therapeutics (MRKR), Pasithea Therapeutics Corp (KTTA) and TransMedics Group (TMDX)
TipRanks News
Bullish
Pasithea Therapeutics: Buy Rating on Differentiated PAS-004, 2026 Clinical Catalysts, and Strengthened Cash Runway
TipRanks News
Bullish
Pasithea Therapeutics provides updated timeline on PAS-004 programs
TipRanks News
Neutral
Pasithea Therapeutics Regains Nasdaq Compliance
TipRanks News
Neutral
Pasithea Therapeutics Completes $60M Public Offering
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
KTTA
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KTTA’s Media Buzz Sentiment?
1 articles about KTTA were published this week. In an average week, 1.25 articles are published.
    What is KTTA’s weekly average amount of articles?
    In an average week, 1.25 articles about KTTA are published.
      What is KTTA’s News Sentiment?
      100% of articles about KTTA were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week